DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/kffz6b/global_metabolic) has announced the addition of the "Global Metabolic Disorders Drug Pipeline Capsule - 2013" report to their offering.
The latest report Global Metabolic Disorders Drug Pipeline Capsule - 2013' provides up-to-date information on key research and development activities in the global metabolic disorders drug market. It covers active pipeline molecules under development in various stages of clinical trials, preclinical research, and drug discovery for Diabetes Mellitus - Type 1, Diabetes Mellitus - Type 2, Diabetic Macular Edema, Diabetic Nephropathy, Diabetic Retinopathy, Dyslipidemia, Lysosomal Storage Diseases, and Obesity.
This report helps executives track their competitor's pipeline molecules. The information presented in this report can be used for identifying partners, evaluating business opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
The report provides information on pipeline molecules by company, mechanism of action, stage (phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and drug discovery), and geography (North America, Europe, and Asia).
Key Features of the Report:
- Metabolic Disorders Drug Pipeline Insights
- Diabetes Mellitus - Type 1 Drug Pipeline Insights
- Diabetes Mellitus - Type 2 Drug Pipeline Insights
- Diabetic Macular Edema Drug Pipeline Insights
- Diabetic Nephropathy Drug Pipeline Insights
- Diabetic Retinopathy Drug Pipeline Insights
- Dyslipidemia Drug Pipeline Insights
- Lysosomal Storage Diseases Drug Pipeline Insights
- Obesity Drug Pipeline Insights
For more information visit http://www.researchandmarkets.com/research/kffz6b/global_metabolic
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.